Deconex IR is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Poly Pharmaceuticals, Inc.. The primary component is Guaifenesin; Phenylephrine Hydrochloride.
Product ID | 50991-736_901f9705-e4e1-4713-97d5-dde06f5f447b |
NDC | 50991-736 |
Product Type | Human Otc Drug |
Proprietary Name | Deconex IR |
Generic Name | Guaifenesin And Phenylephrine Hcl |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2016-08-08 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Poly Pharmaceuticals, Inc. |
Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
Active Ingredient Strength | 385 mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2016-08-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-08-08 |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-08-08 |
Ingredient | Strength |
---|---|
GUAIFENESIN | 385 mg/1 |
SPL SET ID: | 4710095e-3dae-4a39-8a98-873012e1f003 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50991-736 | Deconex IR | Guaifenesin and Phenylephrine HCl |
58552-313 | Gilphex TR | Guaifenesin and Phenylephrine HCl |
69168-354 | Mucus Relief D | Guaifenesin and Phenylephrine HCl |
21130-542 | Mucus Relief PE | Guaifenesin and Phenylephrine HCl |
0904-5792 | Mucus Relief Sinus | Guaifenesin and Phenylephrine HCl |
63187-587 | Mucus Relief Sinus | Guaifenesin and Phenylephrine HCl |
68788-7872 | Mucus Relief Sinus | Guaifenesin and Phenylephrine HCl |
11822-0542 | Sinus Congestion PE | Guaifenesin and Phenylephrine HCl |
68788-0845 | Sinus Congestion PE | Guaifenesin and Phenylephrine HCl |